Quraishi Mohammed Kamil, Badsha Humeira, Khan Bhavna, Shahzeb Muhammad, Hegde Srilakshmi, Mofti Ayman, Ooi Kong Kok
Department of Urology, Medway Maritime Hospital, Kent, England, UK.
Department of Rheumatology. Dr. Humeira Badsha Medical Center, Dubai, UAE.
Open Rheumatol J. 2018 Jan 31;12:10-18. doi: 10.2174/1874312901812010010. eCollection 2018.
The study aimed to demonstrate the interethnic differences and clinical features of Spondyloarthropathy(SpA) patients in a diverse Middle Eastern Country.
A retrospective review of medical records to collect the required data was conducted for SpA patients at two study institutions in the United Arab Emirates.
Of 141 SpA patients found, 88 AS(Ankylosing Spondylitis) patients and 53 'other SpA' patients were identified. Males constituted 81% of AS and 55% of 'other SpA' patients. Patients with AS and 'other SpA' had a mean age of symptom onset of 28 and 34 years, respectively.49% and 40% of AS and 'other SpA' patients had a history of Anti-TNF therapy usage. Enthesitis and Uveitis were noted in 16% and 18% of AS patients whilst 53% and 11% in 'other SpA' patients, respectively.Caucasian, Indian Subcontinent and Arabs constituted 93% of our cohort. Mean age of onset of symptoms in the Indian Subcontinent 'other SpA' group was much greater than the other two ethnicities. Duration of symptoms to diagnosis was 3.5 and 4 years in AS and other SpA patients' respectively. HLA-B27 positivity was found in 53%, 80% and 93% of Arab, Indian Subcontinent and Caucasian AS patients, respectively, whilst seen in 50%, 25% and 33% of the same respective ethnicties in 'other SpA' patients.
This study on 141 patients is the largest to analyse inter-ethnic variations in SpA patients in the region. Our cohort shows a short delay in diagnosis with a relatively higher Anti-TNF usage.
本研究旨在揭示一个多元化中东国家中脊柱关节炎(SpA)患者的种族差异和临床特征。
对阿联酋两家研究机构的SpA患者病历进行回顾性分析,以收集所需数据。
在141例SpA患者中,确诊88例强直性脊柱炎(AS)患者和53例“其他SpA”患者。男性在AS患者中占81%,在“其他SpA”患者中占55%。AS患者和“其他SpA”患者症状出现的平均年龄分别为28岁和34岁。49%的AS患者和40%的“其他SpA”患者有抗TNF治疗史。AS患者中16%出现附着点炎,18%出现葡萄膜炎,而“其他SpA”患者中这一比例分别为53%和11%。白种人、印度次大陆人和阿拉伯人占我们研究队列的93%。印度次大陆“其他SpA”组症状出现的平均年龄远高于其他两个种族。AS患者和其他SpA患者从症状出现到确诊的时间分别为3.5年和4年。阿拉伯、印度次大陆和白种人AS患者中HLA - B27阳性率分别为53%、80%和93%,而在“其他SpA”患者中,相同种族的这一比例分别为50%、25%和33%。
这项对141例患者的研究是该地区分析SpA患者种族差异的最大规模研究。我们的队列显示诊断延迟较短,抗TNF药物使用率相对较高。